DMTC is working with Defence to identify and harness the hazard prediction, modelling and simulation capabilities, expertise and partnering potential of Australian industrial and academic organisations. (more…)
Posted by Harry Baxter on May 24th, 2021 Tagged: collaboration, DMTC, DST, research, technology
A DMTC-supported PhD candidate and young Australian innovator has been awarded a High Commendation in the Land Forces 2021 Innovation Awards.
Harry Veivers has been a driving force in the lightweighting work package of the Thales Australia Networked Future Augmented Small-Arms Technologies (N-FAST) project, successfully manufacturing prototypes using a novel design to achieve a 40% mass reduction. (more…)
Posted by Harry Baxter on May 18th, 2021 Tagged: collaboration, DMTC, DST, innovation, university
Australian industry has a vital role to play in the COVID-19 response, with regard to both developing novel solutions and consolidating supply chain strength in the face of this and potential future pandemic threats. Australian industry has a critical role in ensuring supply of essential therapeutics and active pharmaceutical ingredients for vaccine and drug development. (more…)
Posted by Harry Baxter on October 7th, 2020 Tagged: collaboration, Countermeasures, DMTC, DST, innovation, MCM
A novel Q Fever vaccine is progressing to pre-clinical trials following a $1.87 million investment from the Department of Health into DMTC’s national Medical Countermeasures (MCM) Initiative. (more…)
Posted by Harry Baxter on August 5th, 2020 Tagged: collaboration, Countermeasures, defence technology, DMTC, DST, industry, innovation, technology